A new campaign has been launched focused on helping Australians living with drug-resistant epilepsy to understand available treatment options better and access them sooner.
New 'Mind the Treatment Gap' campaign to focus attention on drug-resistant epilepsy
March 22, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Omico appoints Richard Vines as new Chair as it strengthens national precision oncology agenda
October 23, 2025 - - Latest News -
Island Pharmaceuticals secures FDA response date for Galidesivir approval pathway
October 23, 2025 - - Australian Biotech -
Noxopharm granted first US patent for Sofra immune-modulation platform
October 23, 2025 - - Australian Biotech -
4DMedical secures Stanford as first commercial site and expands AstraZeneca partnership in Brazil
October 23, 2025 - - Australian Biotech -
ImpediMed accelerates growth strategy on strong results and expanding market reach
October 23, 2025 - - Australian Biotech -
Clarity Pharmaceuticals’ copper theranostics platform delivers superior prostate cancer imaging results
October 23, 2025 - - Australian Biotech -
Starpharma receives upfront payment from Genentech, launching oncology collaboration
October 23, 2025 - - Australian Biotech